According to a recently published report by Research Nester on “Cardiac Pacemakers Market: Global Demand Analysis & Opportunity Outlook 2027” delivers detailed overview of the cardiac pacemakers market in terms of market segmentation by product, by technology, by region and by end user.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
Global Cardiac Pacemakers Market is set to achieve significant growth in the next decade and is expected to generate revenues to the tune of more than USD 14 Billion by 2027, owing to various factors predominantly comprising of changing lifestyles, increase in the number of obese people and the rise in old age population across the globe. While World Health Organization (WHO) has reported at least 17 million deaths annually, efforts have been made to find suitable cure for CVDs in order to prevent loss of lives.
The various segments covered under the global cardiac pacemakers market are classified on the basis of product, technology, region and end user. The hospitals falling under end user segment in particular are anticipated to witness the highest growth, owing to the surplus demand arising from this segment all over the globe for conducting various procedures and treatment. The hospitals segment is anticipated to produce record revenue that may cross USD 70 billion with a CAGR of around 6.3% (2019-2027) by the end of 2027.
The pacemaker market has seen a meteoric rise in the past decade which can be attributed to the growing number of individuals affected by CVDs being reported globally. A record 17.9 million deaths arising from CVDs have been reported by World Health Organization (WHO) during the year 2016.
North America particularly United States of America has registered the highest growth during the past decade which accounts for 60% of the total market share globally. Every region barring Europe has been a witness to growing incidences of cardiovascular diseases prevalent in the region that has prompted governments to act accordingly to help detect and prevent CVDs that are endangering human lives.
Some of the key factors that are proving to affect the market negatively are high costs and lack of alternatives, side effects associated with the usage of drugs or treatment as applicable, lack of skilled health care professionals etc.
Barring a few limitations, the market is expected to register a CAGR of around 7.5% during the forecast period i.e. 2019-2027.
This report aims to establish the current competitive scenario of some of the key players of the Cardiac Pacemaker Market accompanied by company profiling of Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, Biotronik Inc., LivaNova PLC, Oscor Inc., Pacetronix, Medico S.p.A. (Italy), Osypka Medical Inc., Lepu Medical and other prominent players. In addition to the same, it seeks to provide valuable key information of the companies that encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the cardiac pacemakers market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
In addition to that, this report also guides existing players looking for expansion and major investors looking for investment in the global waste to energy market in the near future.